Yüklüyor......
Transgenic expression of JAK2(V617F) causes myeloproliferative disorders in mice
The JAK2(V617F) mutation was found in most patients with myeloproliferative disorders (MPDs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. We have generated transgenic mice expressing the mutated enzyme in the hematopoietic system driven by a vav gene promoter....
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2384138/ https://ncbi.nlm.nih.gov/pubmed/18334677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-05-091579 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|